Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s63, 2021. DOI: 10.25251/skin.5.supp.63. Disponível em: https://skin.dermsquared.com/skin/article/view/1414. Acesso em: 18 may. 2025.